{
    "2019-09-26": [
        [
            {
                "time": "2018-07-01",
                "original_text": "Mairs and Power Growth Fund 2nd-Quarter Shareholder Letter",
                "features": {
                    "keywords": [
                        "Mairs",
                        "Power Growth Fund",
                        "Shareholder Letter"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-05",
                "original_text": "6 Declining Stocks in Gurus' Portfolios",
                "features": {
                    "keywords": [
                        "Declining Stocks",
                        "Gurus",
                        "Portfolios"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-06",
                "original_text": "A Big Cancer Conference Starts Tomorrow. Hereâ€™s What It Means for Merck, Bristol-Myers and Other Drug Stocks.",
                "features": {
                    "keywords": [
                        "Cancer Conference",
                        "Merck",
                        "Bristol-Myers",
                        "Drug Stocks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-07",
                "original_text": "Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dividend Stock",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-08",
                "original_text": "Incyte Treats First Patient in Phase III Vitiligo Study",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Phase III",
                        "Vitiligo Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}